Phio Pharmaceuticals Corp. 8-K

What Happened

Phio Pharmaceuticals Corp. announced and filed an 8-K on May 7, 2026 reporting its financial results for the quarterly period ended March 31, 2026. The company furnished a press release with those results as Exhibit 99.1 to the Form 8-K.

Key Details

• Filing date: May 7, 2026 (Current Report on Form 8-K).
• Period reported: Quarterly period ended March 31, 2026.
• Disclosure: Financial results were disclosed via a press release furnished as Exhibit 99.1.
• Technical exhibit: The filing also includes an Inline XBRL cover page (Exhibit 104).

Why It Matters

This 8-K signals that Phio has publicly reported its latest quarterly earnings and financial condition. Retail investors should read the furnished press release (Exhibit 99.1) to see the company’s reported revenue, expenses, cash position, and any management commentary or guidance. The Form 8-K itself confirms timely disclosure but does not replace reviewing the actual press release and accompanying financial statements for detailed earnings information.